Marc Schegerin
Director of Finance/CFO bei MORPHIC HOLDING, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Marc Schegerin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Chief Operating Officer | 06.04.2020 | - |
| Director of Finance/CFO | 06.04.2020 | - | |
| SQZ BIOTECHNOLOGIES COMPANY | Director/Board Member | 23.10.2020 | - |
| Independent Dir/Board Member | 23.10.2020 | - | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Chief Operating Officer | 01.04.2020 | - |
| Director of Finance/CFO | 01.04.2020 | - |
Karriereverlauf von Marc Schegerin
Ehemalige bekannte Positionen von Marc Schegerin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARQULE, INC. | Director of Finance/CFO | 29.03.2019 | 01.01.2020 |
| Public Communications Contact | 24.05.2018 | 29.03.2019 | |
| CITIGROUP INC. | Director/Board Member | 01.06.2016 | 01.04.2018 |
| SAGE THERAPEUTICS, INC. | Director/Board Member | 01.01.2013 | 01.01.2014 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2009 | 01.01.2013 |
Ausbildung von Marc Schegerin
| Harvard University | Undergraduate Degree |
| Tulane University (Louisiana) | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 12 |
Operativ
| Director/Board Member | 3 |
| Director of Finance/CFO | 3 |
| Chief Operating Officer | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 5 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| CITIGROUP INC. | Finance |
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Marc Schegerin
- Erfahrung
